Ontology highlight
ABSTRACT:
SUBMITTER: Mason JM
PROVIDER: S-EPMC5296225 | biostudies-literature | 2017 Feb
REPOSITORIES: biostudies-literature
Mason Jennifer M JM Yuan Hongling H Evans Gary B GB Tyler Peter C PC Du Quan Q Schramm Vern L VL
European journal of medicinal chemistry 20161027
Ribosome inactivating proteins (RIPs) are among the most toxic agents known. More than a dozen clinical trials against refractory cancers have been initiated using modified RIPs with impressive results. However, dose-limiting toxicity due to vascular leak syndrome limits success of the therapy. We have previously reported some tight-binding transition state analogues of Saporin L3 that mimic small oligonucleotide substrates in which the susceptible adenosine has been replaced by a 9-deazaadenyl ...[more]